Nanotech to help improve medical tests
A laboratory test used to detect disease and perform biological research could be made more than 3 million times more sensitive, according to Princeton researchers.
The increased performance could greatly improve the early detection of cancer, Alzheimer’s disease and other disorders by allowing doctors to detect far lower concentrations of telltale markers than was previously practical.
The breakthrough involves a common biological test called an immunoassay, which mimics the action of the immune system to detect the presence of biomarkers — the chemicals associated with diseases. When biomarkers are present in samples, such as those taken from humans, the immunoassay test produces a fluorescent glow (light) that can be measured in a laboratory.
The greater the glow, the more of the biomarker is present. However, if the amount of biomarker is too small, the fluorescent light is too faint to be detected, setting the limit of detection. A major goal in immunoassay research is to improve the detection limit.
To read this Kurzweil AI article in full, click here.
There have been 0 replies to this Article. + Post your comment here.
All opinions are welcome but comments are checked to ensure they are not abusive or profane